文献速递甲状腺疾病糖尿病

妊娠早期甲状腺功能与TPOAb对妊娠结局的影响:北京回顾性研究

The Impact of Thyroid Function and TPOAb in the First Trimester on Pregnancy Outcomes: A Retrospective Study in Peking.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该回顾性研究纳入3562例孕妇,评估早孕期轻度TSH升高(2.5-4.08 mIU/L)合并TPOAb状态对妊娠结局的影响及左甲状腺素治疗效果。结果显示TSH 2.5-4.08 mIU/L且TPOAb阴性者流产和母体复合结局风险增加,L-T4治疗利弊尚不确定。

要点

  • 早孕期TSH 2.5-4.08 mIU/L且TPOAb阴性者流产及母体复合结局风险升高
  • TSH 2.5-4.08 mIU/L孕妇使用L-T4的获益与风险尚不明确
  • L-T4治疗使TSH 2.5-4.08 mIU/L组妊娠期糖尿病风险加倍

核心结论

  • 早孕期TSH 2.5-4.08 mIU/L合并TPOAb阴性可能与流产和母体复合结局相关。
  • TSH 2.5-4.08 mIU/L孕妇使用L-T4治疗的利弊仍不确定。

研究设计与样本

  • 回顾性研究,纳入3562例孕妇,其中3296例未治疗者分为4个亚组,266例接受L-T4治疗者分为2个亚组。

主要发现

  • L-T4治疗改善了TSH 4.08-10 mIU/L和2.5-4.08 mIU/L组的流产风险。
  • L-T4治疗使TSH 2.5-4.08 mIU/L组的妊娠期糖尿病风险较未治疗组加倍。

临床怎么用

  • 对早孕期TSH 2.5-4.08 mIU/L且TPOAb阴性的孕妇应关注流产和母体复合结局风险。
  • 对TSH 2.5-4.08 mIU/L孕妇启动L-T4治疗需权衡流产获益与妊娠期糖尿病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The impact of mild TSH elevation (2.5-4.08 mIU/L) on pregnancy outcomes is unclear. The treatment strategy for mild TSH elevation is dependent on thyroid peroxidase antibody (TPOAb) status according to the guidelines. OBJECTIVE: To assess the effects of mild thyroid dysfunction combined with TPOAb status in the first trimester on pregnancy outcomes and the impact of levothyroxine (L-T4) treatment on pregnancy outcomes. DESIGN: The study retrospectively evaluated 3562 pregnant women. A total of 3296 untreated women were divided into 4 subgroups: group A: 4.08 < TSH <10 mIU/L, TPOAb+/-; group B: 2.5 < TSH ≤ 4.08 mIU/L, TPOAb+; group C: 2.5 < TSH ≤ 4.08 mIU/L, TPOAb-; and group D: 0.23 ≤ TSH ≤ 2.5 mIU/L, TPOAb+/-. The other 266 women with L-T4 treatment were divided into TSH 4.08 to 10 mIU/L and 2.5 to 4.08 mIU/L subgroups. SETTING: The study was conducted at Peking University First Hospital in China. PATIENTS: A total of 3562 pregnant women were evaluated. MAIN OUTCOME MEASURES: The incidence of pregnancy outcomes in the untreated subgroups (groups A-D) and treated subgroups were measured. RESULTS: Miscarriage and maternal composite outcome risks were 3.53 (1.85-6.75) and 2.19 (1.26-3.81) times greater in group A; 1.58 (1.17-2.13) and 1.27 (1.04-1.54) times greater in group C than in group D. L-T4 improved the miscarriage risk in the TSH 4.08 to 10 and 2.5 to 4.08 mIU/L groups but doubled the risk of gestational diabetes mellitus in the TSH 2.5 to 4.08 mIU/L treated group compared with the untreated group. CONCLUSIONS: TSH 2.5 to 4.08 mIU/L combined with TPOAb- during early pregnancy was associated with miscarriages and maternal composite outcomes. The advantages and disadvantages of L-T4 administration in TSH 2.5 to 4.08 mIU/L pregnant women remain uncertain.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Sun W, Zhu S, et al. The Impact of Thyroid Function and TPOAb in the First Trimester on Pregnancy Outcomes: A Retrospective Study in Peking. J Clin Endocrinol Metab. 2020. PMID: 31677603. doi:10.1210/clinem/dgz167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。